VR Logo

Glaxosmithkline Pharmaceuticals Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1924

Chairman: R S Karnad

Managing Director: S Venkatesh

Group: Glaxosmithkline - MNC

Listing: NSE: GLAXO, BSE: 500660

Headquarters: Mumbai, Maharashtra

Website: www.gsk-india.com

Key Facts

Market cap: R 25,038.21 Cr

Revenue (TTM): R 3,085.00 Cr

Earnings (TTM): R 90.49 Cr

Cash: R 1,083.20 Cr

Total Debt: R 0.18 Cr

Promoters' ownership: 75.00%

Liquidity: High

52 Week range: R 962.65 - 1,807.50

Face value: R10.00

Shares outstanding: 16,94,06,034

10 Years Aggregate:

  • CFO: 3,493.33 Cr
  • EBITDA: 5,930.02 Cr
  • Net Profit: 4,129.09 Cr

Stock Performance

Time Period Glaxosmithkline Pharma S&P BSE Healthcare S&P BSE Mid Cap
YTD-6.9344.49-1.03
1 month-4.95-2.180.63
3 months2.3514.378.38
1 Year-3.3649.112.57
3 Years5.6811.10-3.29
5 Years-1.801.406.06
10 Years2.8711.675.86
As on 28-Oct-2020
Year Glaxosmithkline Pharma S&P BSE Mid Cap S&P BSE Healthcare
20197.50-3.05-3.55
201821.62-13.31-5.89
2017-8.8148.130.49
2016-17.157.97-12.88
20154.557.4315.06
20146.9654.6947.43
201339.74-5.7322.55